167 related articles for article (PubMed ID: 20223128)
1. [Reply to editorial comment on article "Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level <5ng/ml"].
Rioja Zuazu J; Zudaire Bergera JJ; Richter JA; Berián Polo JM
Actas Urol Esp; 2010 Jan; 34(1):12-4. PubMed ID: 20223128
[No Abstract] [Full Text] [Related]
2. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
Greco C; Cascini GL; Tamburrini O
Prostate Cancer Prostatic Dis; 2008; 11(2):121-8. PubMed ID: 18180806
[TBL] [Abstract][Full Text] [Related]
4. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
[TBL] [Abstract][Full Text] [Related]
5. [Comments on article "Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level <5"].
Briones JR
Actas Urol Esp; 2009 Sep; 33(8):841. PubMed ID: 19900374
[No Abstract] [Full Text] [Related]
6. [Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml].
Rioja Zuazu J; Rodríguez M; Rincón Mayans A; Sansi AS; Zudaire Bergera JJ; Martínez-Monge R; Richter JA; Berián Polo JM
Actas Urol Esp; 2009 Sep; 33(8):844-52. PubMed ID: 19900376
[TBL] [Abstract][Full Text] [Related]
7. Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?
Vargas HA; Martin-Malburet AG; Takeda T; Corradi RB; Eastham J; Wibmer A; Sala E; Zelefsky MJ; Weber WA; Hricak H
Urol Oncol; 2016 Nov; 34(11):482.e5-482.e10. PubMed ID: 27346339
[TBL] [Abstract][Full Text] [Related]
8. Role of
Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596
[TBL] [Abstract][Full Text] [Related]
9. Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer.
Bucerius J; Ahmadzadehfar H; Hortling N; Joe AY; Palmedo H; Biersack HJ
Prostate Cancer Prostatic Dis; 2007; 10(3):307-10. PubMed ID: 17353915
[TBL] [Abstract][Full Text] [Related]
10. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
11. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
[TBL] [Abstract][Full Text] [Related]
12. [Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Cochet A; Kanoun S; Humbert O; Walker PM; Cormier L; Créhange G; Brunotte F
Cancer Radiother; 2014 Oct; 18(5-6):509-16. PubMed ID: 25195114
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
Queiroz MA; Viana P; Santos A; Bastos D; Etchebehere E; Cerri G
Clin Nucl Med; 2016 Sep; 41(9):e417-9. PubMed ID: 27276202
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view.
Schiavina R; Brunocilla E; Borghesi M; Vagnoni V; Castellucci P; Nanni C; Ceci F; Gacci M; Martorana G; Fanti S
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):310-3. PubMed ID: 23933383
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. [Solitary hypermetabolic bone focus in the initial extension study of a prostate carcinoma].
Sampol Bas C; Peña Viloria C; Giménez García M
Rev Esp Med Nucl; 2005; 24(6):414-7. PubMed ID: 16324519
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?
Heinisch M; Dirisamer A; Loidl W; Stoiber F; Gruy B; Haim S; Langsteger W
Mol Imaging Biol; 2006; 8(1):43-8. PubMed ID: 16315004
[TBL] [Abstract][Full Text] [Related]
18. [Circulating prostatic-specific antigen in benign hypertrophy and localized prostate cancer: can PSA be considered a screening examination for localized cancer?].
Perrin P; Francois O; Maquet JH; Bringeon G; Duteil P; Devonec M
Prog Urol; 1991 Jun; 1(3):419-31. PubMed ID: 1726943
[TBL] [Abstract][Full Text] [Related]
19. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
20. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
